Ginkgo Bioworks Holdings, Inc.
DNA
$10.13
-$0.63-5.86%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -315.19M | -472.08M | -547.03M | -651.19M | -897.68M |
| Total Depreciation and Amortization | 63.98M | 65.52M | 63.02M | 60.21M | 64.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 143.64M | 226.26M | 254.09M | 305.80M | 482.13M |
| Change in Net Operating Assets | -130.14M | -101.55M | -89.67M | -49.79M | 46.42M |
| Cash from Operations | -237.71M | -281.85M | -319.59M | -334.98M | -305.03M |
| Capital Expenditure | -36.46M | -63.45M | -62.54M | -52.28M | -41.57M |
| Sale of Property, Plant, and Equipment | 457.00K | 457.00K | 457.00K | 1.83M | 1.50M |
| Cash Acquisitions | 0.00 | 0.00 | -5.40M | -5.40M | -5.40M |
| Divestitures | -- | -- | -- | -42.98M | -42.98M |
| Other Investing Activities | -249.86M | -185.81M | 5.25M | 3.00M | -559.00K |
| Cash from Investing | -285.86M | -248.81M | -62.24M | -95.83M | -89.01M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -708.00K | -810.00K | -897.00K | -1.01M | -1.14M |
| Issuance of Common Stock | 0.00 | 14.00K | 84.00K | 98.00K | 153.00K |
| Repurchase of Common Stock | -- | -- | -- | -23.00K | -23.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -265.00K | -305.00K | -926.00K | -1.23M | -1.01M |
| Cash from Financing | -973.00K | -1.10M | -1.74M | -2.17M | -2.02M |
| Foreign Exchange rate Adjustments | 152.00K | -50.00K | -281.00K | -106.00K | -266.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -524.39M | -531.81M | -383.84M | -433.08M | -396.32M |